ESOPApr 13, 2026, 04:07 PM
BBOT Grants 32,675 Stock Options to New Employee
AI Summary
BridgeBio Oncology Therapeutics, Inc. (BBOT) announced it awarded inducement grants of non-qualified stock options for 32,675 shares to a new employee hired in March 2026. The options, with an exercise price of $8.40 per share, were granted under BBOT's 2025 Inducement Plan as a material inducement for employment. Vesting occurs 1/4 on the first anniversary of the start date, followed by 36 equal monthly installments.
Key Highlights
- Granted 32,675 non-qualified stock options to a new employee.
- Exercise price set at $8.40 per share.
- Vesting: 25% after one year, then monthly over three years.
- Options granted under the 2025 Inducement Plan.
Price Impact
More from BBOT